Reduced levels of a critical protein are linked to devastating brain diseases like Alzheimer's, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). Surprisingly, the protein shortage ...

Hollywood actor Selma Blair shared an update on her health battle with multiple sclerosis - revealing a groundbreaking ...

Hollywood actor Selma Blair shared an update on her health battle with multiple sclerosis - revealing a groundbreaking ...

Vidofludimus calcium reduced the risk of 24-week confirmed disability worsening and slowed brain shrinkage in people with ...

Brian Compton, the managing editor/days at NHL.com was diagnosed with multiple sclerosis. It was stunning news for Brian, who ...

A study has discovered that people with MS often experience constipation, urinary tract infections, bladder infections, ...

According to CEO Daniel Vitt, clinical and disability-related outcomes are more relevant than brain volume change for drug ...

Researchers at the University of Turku have identified a new predictor for multiple sclerosis progression: the thickness of ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

Immunic’s lead oral small molecule has failed to hit the primary endpoint of a phase 2 trial in patients with progressive ...

Updates in relapsing-remitting MS from AAN 2025 examine neurofilament light protein level as a prognostic biomarker, safety and efficacy of ofatumumab, and benefit of early initiation of ozanimod.

Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...